NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...

On track for readout of RASolute 302, a Phase 3 trial of daraxonrasib in second line metastatic PDAC, in first half of 2026Continues to advance broad late-stage pipeline, with five ongoing Phase 3 ...

Most people fear a dramatic, painful end. Hospice experience reveals a quieter truth that may ease anxiety and change how you think about death.

Ingesting baking soda, which is a base, helps to counteract the rising acidity and reduce the associated muscle fatigue. At high altitudes, lower levels of oxygen in the air mean that your muscles ...

The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...

Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

Waldorf schools tend to attract parents who don’t want their kids to eat junk food or play Fortnite; they also draw a fair number who skip vaccines. During the pandemic, I began to hear considerable ...

Phentolamine is framed as a differentiated, preservative-free sympatholytic approach that modulates pupil dynamics without ciliary muscle activation, targeting near-vision improvement while ...

A wave of research published during the past year is strengthening what scientists demonstrated over several decades: ...

Dupixent (dupilumab) is now FDA-approved for adults and children aged 6 years and older with allergic fungal rhinosinusitis and prior sino-nasal surgery.

EVO301, a long-acting, injectable interleukin-18 binding protein, rapidly improved moderate to severe atopic dermatitis in ...